2026 Program
October 29, 2026
By the end of this symposium, participants will be able to describe recent discoveries in clinical and translational research and innovations in care for patients with vasculitis, which aims to improve the long term outcomes
Welcome and Opening Remarks
7:50 am
Presented by the Symposium Planning Committee
Treating ANCA Associated Vasculitis: Towards Personalizing Treatment
8:00 am
Presented by Dr. Michael Walsh
Objective: By the end of this session, participants will be able to review the major outcomes of patients with ANCA-associated vasculitis, evaluate available risk prediction instruments, and discuss emerging clinical trials and future developments in the field.
IgG4 Disease
9:00 am
Presented by Drs. Aurore-Fifi Mah & Lynn Cornell
Objective: By the end of this session, participantswill be able to recognize the clinical features, understand the pathophysiology, and apply appropriate diagnostic and management strategies for IgG4-related disease.
Interesting Case #1
9:45 am
Presented by Hanna Lasky
Objective: By the end of this session, participants will be able to reflect on the case and the implications for their clinical practice.
Interesting Case #2
10:00 am
Presented by Dr. Audrea Chen
Objective: By the end of this session, participants will be able to reflect on the case and the implications for their clinical practice.
Break
10:15 am
PedVas an International Registry on Childhood Vasculitis
10:45 am
Presented by Dr. Kim Morishita
Objective: By the end of this session. participants will be able to describe the role of PedVas and international registries in improving the diagnosis, management, and research of pediatric vasculitis.
Vasculitis Fellows Presentation
11:30 am
Presented by Dr. Vivien De Paula Mantovani Joaquim
Objective: By the end of this session, participants will be able to evaluate the value of Vasculitis Fellowships and their impact on career development.
Vasculitis Fellows Presentation
11:45 am
Presented by Dr. Lia Anish
Objective: By the end of this session, participants will be able to evaluate the value of Vasculitis Fellowships and their impact on career development.
Lunch
12:00 pm
Kawasaki Disease; Updated Guidelines and Practical Points
12:45 pm
Presented by Dr. Audrea Chen
Objective: By the end of this session, participants will be able to have a better understanding of how to recognize, diagnose, and manage Kawasaki disease using updated guidelines to prevent complications.
Interesting Case #3
1:25 pm
Presented by Dr. Eliana Magalí Ramos Galeano
Objective: By the end of this session, participants will be able to reflect on the case and the implications for their clinical practice.
Interesting Case #4
1:40 pm
Presented by Dr. Tom Beechinor
Objective: By the end of this session, participants will be able to reflect on the case and the implications for their clinical practice.
Break
1:55 pm
Assessment of Health-Related Quality of Life in Patients with Vasculitis Living in Canada
2:30 pm
Presented by Dr. Rume Djebah
Objective: By the end of the session, the participant will be able to describe the impact of vasculitis on health-related quality of life among patients living in Canada and identify key factors influencing patient-reported outcomes.
Keynote: Complement Cascade Blockers in ANCA Vasculitis - Hope or Hype?
3:00 pm
Presented by Dr. Christoph Licht
Objective: By the end of the session, the participant will be able to evaluate the mechanism of action, clinical evidence, and therapeutic role of complement cascade inhibitors in ANCA-associated vasculitis, and to assess whether they represent a meaningful advancement over conventional therapies or remain an emerging approach.
Closing Remarks
4:00 pm
Presented by the Symposium Planning Committee